![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 47, 36645-36652, November 24, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The structural and antigenic properties of a
peptide ("CRK") derived from the V3 loop of HIV-1 gp120 protein
were studied using NMR and SPR techniques. The sequence of CRK
corresponds to the central portion of the V3 loop containing the highly
conserved "GPGR" residue sequence. Although the biological
significance of this conserved sequence is unknown, the adoption of
conserved secondary structure (type II
The Binding of a Glycoprotein 120 V3 Loop Peptide to HIV-1
Neutralizing Antibodies
STRUCTURAL IMPLICATIONS*
§,
, and
**
Department of Chemistry, University of
Cincinnati, Cincinnati, Ohio 45221-0172, the ¶ Institute for
Biological Sciences, National Research Council, 100 Sussex Drive,
Ottawa, Ontario K1A 0R6, Canada, and the
Department of
Pathology, Massachusetts General Hospital,
Boston, Massachusetts 02115
-turn) in this region has
been proposed. The tendency of CRK (while free or conjugated to
protein), to adopt such structure and the influence of such structure
upon CRK antigenicity were investigated by NMR and SPR, respectively. Regardless of conjugation, CRK is conformationally averaged in solution
but a weak tendency of the CRK "GPGR" residues to adopt a
-turn
conformation was observed after conjugation. The influence of GPGR structure upon CRK antigenicity was investigated by
measuring the affinities of two cognate antibodies: "5023A" and
"5025A," for CRK, protein-conjugated CRK and gp120 protein. Each
antibody bound to all the antigens with nearly the same affinity. From these data, it appears that: (a) antibody binding most
likely involves an induced fit of the peptide and (b) the gp120 V3 loop is probably conformationally heterogeneous. Since 5023A and 5025A are
HIV-1 neutralizing antibodies, neutralization in these cases appears to
be independent of adopted GPGR
-turn structure.
*
This work was supported by National Institutes of Health,
NIGMS Grant GM-47013.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
R. L. Stanfield, M. K. Gorny, S. Zolla-Pazner, and I. A. Wilson Crystal Structures of Human Immunodeficiency Virus Type 1 (HIV-1) Neutralizing Antibody 2219 in Complex with Three Different V3 Peptides Reveal a New Binding Mode for HIV-1 Cross-Reactivity. J. Virol., June 1, 2006; 80(12): 6093 - 6105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dumonceaux, C. Goujon, V. Joliot, P. Briand, and U. Hazan Determination of Essential Amino Acids Involved in the CD4-Independent Tropism of the X4 Human Immunodeficiency Virus Type 1 m7NDK Isolate: Role of Potential N Glycosylations in the C2 and V3 Regions of gp120 J. Virol., June 1, 2001; 75(11): 5425 - 5428. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |